Merck Correlations
| MRCK34 Stock | BRL 79.48 1.95 2.52% |
The current 90-days correlation between Merck and AbbVie Inc is 0.2 (i.e., Modest diversification). The correlation of Merck is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Merck Correlation With Market
Poor diversification
The correlation between Merck Co and DJI is 0.74 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merck Co and DJI in the same portfolio, assuming nothing else is changed.
Merck |
The ability to find closely correlated positions to Merck could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck Co to buy it.
Moving together with Merck Stock
| 0.86 | JNJB34 | Johnson Johnson | PairCorr |
| 0.86 | BMYB34 | Bristol Myers Squibb | PairCorr |
| 0.61 | GILD34 | Gilead Sciences | PairCorr |
| 0.76 | SPTW11 | Sp Downtown Fundo | PairCorr |
| 0.83 | HGBS11 | HEDGE Brasil Shopping | PairCorr |
| 0.79 | BCPX39 | Global X Funds Split | PairCorr |
| 0.66 | ITUB4 | Ita Unibanco Holding Split | PairCorr |
| 0.74 | B1SA34 | Banco Santander Chile | PairCorr |
| 0.69 | RCSL4 | Recrusul SA | PairCorr |
| 0.64 | WUNI34 | Western Union | PairCorr |
| 0.64 | L1HX34 | L3Harris Technologies | PairCorr |
| 0.67 | BBSE3 | BB Seguridade Partic | PairCorr |
| 0.73 | ABUD34 | Anheuser Busch InBev | PairCorr |
| 0.65 | B1TI34 | British American Tobacco | PairCorr |
| 0.67 | PETZ3 | Pet Center Comrcio | PairCorr |
| 0.68 | WEGE3 | WEG SA | PairCorr |
| 0.75 | M1CH34 | Microchip Technology | PairCorr |
| 0.79 | T1EC34 | TechnipFMC plc | PairCorr |
| 0.82 | PNVL3 | Dimed SA Distribuidora | PairCorr |
Moving against Merck Stock
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Merck Corporate Management
Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cristal Downing | Ex Officer | Profile | |
| Jennifer Zachary | General Counsel | Profile | |
| David Williams | Ex Officer | Profile | |
| Caroline Litchfield | Ex CFO | Profile | |
| Lisa LeCointeCephas | VP Officer | Profile |